Dr. Argiles Discusses the Role of Immunotherapy in CRC – OncLive
OncLive |
Dr. Argiles Discusses the Role of Immunotherapy in CRC
OncLive Guillem Argiles, MD, staff member, Gastrointestinal Malignancies Division, Vall d'Hebron University Hospital, discusses the role of immunotherapy in colorectal cancer (CRC). There is an important role for immunotherapy in the hyper-mutant population of … |
